Innovate and Elevate: Integris Medtech Files IPO Led by ICICI and Axis Capital to Raise Rs 9.25 Billion Fresh Capital

Updated: October 10, 2025 13:00

Image Source: Express Healthcare

Integris Medtech, a leading diversified medical devices company in India, has filed draft papers for its IPO comprised of a fresh issue worth Rs 9.25 billion and an offer for sale of 21.7 million shares. ICICI Securities and Axis Capital lead the offering as book running managers.

Integris Medtech, a prominent name in India’s medical devices sector, has taken a major step towards scaling its business by filing draft papers for an Initial Public Offering (IPO). The IPO features a fresh issue size of Rs 9.25 billion alongside an offer for sale involving 21.7 million equity shares, aimed at unlocking growth capital for strategic expansion.

The company has appointed leading investment banks ICICI Securities and Axis Capital as book running lead managers for the IPO. The issuance of shares will allow Integris Medtech to finance its planned investments in research and development, manufacturing scale-up, and potential acquisitions across key therapeutic areas including in-vitro diagnostics and cardiovascular devices.

Key Highlights of Integris Medtech IPO:

Fresh issue valuing Rs 9.25 billion to fuel expansion and innovation.
An offer for sale of 21.7 million shares indicating promoter shareholding adjustments.
ICICI Securities and Axis Capital to manage the IPO, ensuring wide market reach.
Planned use of proceeds includes R&D, capacity augmentation, working capital, and strategic acquisitions.
Integris Medtech positioned to capitalize on the fast-growing domestic and global medical devices market.
Backed by experienced leadership under CEO Probir Das, appointed in 2024 to drive growth.
Company’s integrated operations span product development, manufacturing, and global sales presence.
Manufacturing bases in India, Germany, and Netherlands underpin global compliance and quality.

Strong distribution network targeting over 50 markets.

Integris Medtech’s IPO launch is set against a backdrop of rapid growth in India’s healthcare devices industry, driven by increasing demand for technologically advanced and cost-effective solutions. The company’s integrated approach of combining cutting-edge R&D with manufacturing efficiency makes it well-positioned to attract investor interest.

This IPO represents a significant milestone for Integris Medtech in its vision to emerge as a global med-tech leader, empowering better healthcare through innovation.

Sources: Digital Health News, Express Healthcare, Entrackr, Everstone Capital

Stay Ahead – Explore Now! JSW Steel CEO Flags MET Coke Import Curbs as Significant Concern for Producers

STORIES YOU MAY LIKE

Image Source: Air India

Air India Partners with Scoot to Expand Connectivity Across Asia and Australasia

Image Source: Live Law

Aditya Birla Fashion Faces ₹69 Million Tax Demand; Company to Appeal Order

Image Source: RealtynMore

Ashiana Housing approves debentures issuance up to ₹500 million via private placement

Image Source: Linkedln

Market Creators Ltd Appoints Vaishali Shah as Chief Financial Officer to Drive Financial Strategy

Image Source: Money Mint idea

Sahaj Solar Secures ₹357.5 Million Order, Strengthens Renewable Energy Portfolio

Image Source: Mint

RMC Switchgears Powers Ahead with 8.8 MWAC Commissioning for MAHAGENCO Solar Project

Strategic Win: Alembic Pharma Secures USFDA Approval with 180 Day Market Exclusivity

Top Searches

Suggestions

Innovate and Elevate: Integris Medtech Files IPO Led by ICICI and Axis Capital to Raise Rs 9.25 Billion Fresh Capital

STORIES YOU MAY LIKE

Live Blogs

Top Stories

Innovate and Elevate: Integris Medtech Files IPO Led by ICICI and Axis Capital to Raise Rs 9.25 Billion Fresh Capital

STORIES YOU MAY LIKE

Subscribe to receive the day's headlines from WOWNEWS 24X7 straight in your inbox

Live Blogs

Top Stories